vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $766.5M, roughly 1.4× SCANSOURCE, INC.). SCANSOURCE, INC. runs the higher net margin — 2.2% vs -127.8%, a 130.0% gap on every dollar of revenue. On growth, SCANSOURCE, INC. posted the faster year-over-year revenue change (2.5% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $28.9M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs 0.9%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
PRGO vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $766.5M |
| Net Profit | $-1.4B | $16.5M |
| Gross Margin | 32.6% | 13.4% |
| Operating Margin | -116.0% | 2.3% |
| Net Margin | -127.8% | 2.2% |
| Revenue YoY | -2.5% | 2.5% |
| Net Profit YoY | -3093.9% | -3.3% |
| EPS (diluted) | $-10.23 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $766.5M | ||
| Q3 25 | $1.0B | $739.6M | ||
| Q2 25 | $1.1B | $812.9M | ||
| Q1 25 | $1.0B | $704.8M | ||
| Q4 24 | $1.1B | $747.5M | ||
| Q3 24 | $1.1B | $775.6M | ||
| Q2 24 | $1.1B | $746.1M | ||
| Q1 24 | $1.1B | $752.6M |
| Q4 25 | $-1.4B | $16.5M | ||
| Q3 25 | $7.5M | $19.9M | ||
| Q2 25 | $-8.4M | $20.1M | ||
| Q1 25 | $-6.4M | $17.4M | ||
| Q4 24 | $-44.4M | $17.1M | ||
| Q3 24 | $-21.0M | $17.0M | ||
| Q2 24 | $-108.4M | $16.1M | ||
| Q1 24 | $2.0M | $12.8M |
| Q4 25 | 32.6% | 13.4% | ||
| Q3 25 | 36.1% | 14.5% | ||
| Q2 25 | 34.4% | 12.9% | ||
| Q1 25 | 37.6% | 14.2% | ||
| Q4 24 | 33.9% | 13.6% | ||
| Q3 24 | 37.2% | 13.1% | ||
| Q2 24 | 37.0% | 13.0% | ||
| Q1 24 | 33.1% | 12.6% |
| Q4 25 | -116.0% | 2.3% | ||
| Q3 25 | 7.0% | 3.5% | ||
| Q2 25 | 4.3% | 3.3% | ||
| Q1 25 | 4.5% | 3.2% | ||
| Q4 24 | 10.0% | 2.5% | ||
| Q3 24 | 7.4% | 2.3% | ||
| Q2 24 | -2.5% | 2.9% | ||
| Q1 24 | -5.1% | 2.3% |
| Q4 25 | -127.8% | 2.2% | ||
| Q3 25 | 0.7% | 2.7% | ||
| Q2 25 | -0.8% | 2.5% | ||
| Q1 25 | -0.6% | 2.5% | ||
| Q4 24 | -3.9% | 2.3% | ||
| Q3 24 | -1.9% | 2.2% | ||
| Q2 24 | -10.2% | 2.2% | ||
| Q1 24 | 0.2% | 1.7% |
| Q4 25 | $-10.23 | $0.75 | ||
| Q3 25 | $0.05 | $0.89 | ||
| Q2 25 | $-0.06 | $0.87 | ||
| Q1 25 | $-0.05 | $0.74 | ||
| Q4 24 | $-0.32 | $0.70 | ||
| Q3 24 | $-0.15 | $0.69 | ||
| Q2 24 | $-0.79 | $0.66 | ||
| Q1 24 | $0.01 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $83.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9B | $910.9M |
| Total Assets | $8.5B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $83.5M | ||
| Q3 25 | $432.1M | $124.9M | ||
| Q2 25 | $454.2M | $126.2M | ||
| Q1 25 | $409.9M | $146.3M | ||
| Q4 24 | $558.8M | $110.5M | ||
| Q3 24 | $1.5B | $145.0M | ||
| Q2 24 | $542.8M | $185.5M | ||
| Q1 24 | $658.5M | $159.1M |
| Q4 25 | $2.9B | $910.9M | ||
| Q3 25 | $4.4B | $914.0M | ||
| Q2 25 | $4.5B | $906.4M | ||
| Q1 25 | $4.4B | $901.7M | ||
| Q4 24 | $4.3B | $900.7M | ||
| Q3 24 | $4.6B | $920.9M | ||
| Q2 24 | $4.5B | $924.3M | ||
| Q1 24 | $4.7B | $944.1M |
| Q4 25 | $8.5B | $1.7B | ||
| Q3 25 | $10.1B | $1.7B | ||
| Q2 25 | $10.1B | $1.8B | ||
| Q1 25 | $9.8B | $1.7B | ||
| Q4 24 | $9.6B | $1.7B | ||
| Q3 24 | $11.2B | $1.8B | ||
| Q2 24 | $10.4B | $1.8B | ||
| Q1 24 | $10.6B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $30.8M |
| Free Cash FlowOCF − Capex | $148.6M | $28.9M |
| FCF MarginFCF / Revenue | 13.4% | 3.8% |
| Capex IntensityCapex / Revenue | 2.4% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $30.8M | ||
| Q3 25 | $51.7M | $23.2M | ||
| Q2 25 | $75.9M | — | ||
| Q1 25 | $-64.5M | $66.1M | ||
| Q4 24 | $312.6M | $-6.2M | ||
| Q3 24 | $42.2M | $44.8M | ||
| Q2 24 | $9.5M | — | ||
| Q1 24 | $-1.4M | $160.2M |
| Q4 25 | $148.6M | $28.9M | ||
| Q3 25 | $29.8M | $20.8M | ||
| Q2 25 | $56.7M | — | ||
| Q1 25 | $-90.0M | $64.6M | ||
| Q4 24 | $274.9M | $-8.2M | ||
| Q3 24 | $15.1M | $42.5M | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-26.5M | $157.7M |
| Q4 25 | 13.4% | 3.8% | ||
| Q3 25 | 2.9% | 2.8% | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | -8.6% | 9.2% | ||
| Q4 24 | 24.2% | -1.1% | ||
| Q3 24 | 1.4% | 5.5% | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -2.4% | 21.0% |
| Q4 25 | 2.4% | 0.3% | ||
| Q3 25 | 2.1% | 0.3% | ||
| Q2 25 | 1.8% | 0.3% | ||
| Q1 25 | 2.4% | 0.2% | ||
| Q4 24 | 3.3% | 0.3% | ||
| Q3 24 | 2.5% | 0.3% | ||
| Q2 24 | 2.7% | 0.2% | ||
| Q1 24 | 2.3% | 0.3% |
| Q4 25 | — | 1.87× | ||
| Q3 25 | 6.89× | 1.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.79× | ||
| Q4 24 | — | -0.36× | ||
| Q3 24 | — | 2.64× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.70× | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
